Support the Future of Breast Cancer Research and Treatment
Gifts to the Shula Fund support a wide variety of innovative breast cancer research and education activities at Moffitt Cancer Center that include:
There is no better way to impact the future of breast cancer survival than with the creation of clinical trials. Your support can help fund the development of innovative clinical studies that offer new ways to treat various stages of breast cancer and improve patient outcomes – and in the process, bring hope to patients and families.
Precision Medicine and Immunotherapy
A wide variety of research activities are underway to address the very unique needs of each breast cancer patient – from developing clinic trials to prevent recurrence in HER2-positive patients to studying immune response in individuals who become resistant to current therapies.
Scientists also are developing novel immunotherapies, including vaccines, against lethal forms of breast cancer and other solid-tumor cancers. You can be on the ground floor of helping to create new therapies that may potentially reduce or eliminate the need for chemotherapy, surgery and radiation.
Educating Tomorrow’s Oncologists and Scientists
Education and training is a fundamental part of our core mission at Moffitt, and the Breast Oncology Program is no exception. Funding is particularly appreciated to help support educational opportunities for faculty and other clinical professionals; visiting scholars; postdoctoral, graduate and undergraduate students; and high school students.
Interested in Learning More?
For more information on how you can support the Breast Oncology Program at Moffitt Cancer Center and learn more about upcoming educational events, please click here to leave your email address and receive more information, or contact Carrie Bien, Associate Director of Individual and Family Giving, at 813-745-4039 or email@example.com.
TOGETHER WE CAN CHANGE LIVES TODAY
CONTACT USMoffitt Cancer Center Foundation
12902 Magnolia Drive
Tampa, FL 33612 1-800-456-3434, ext. 1403